INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 27 Feb · 11:58 IST

Disclosure under Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories Limited has made a disclosure to the stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. This regulation requires listed companies to inform exchanges about any material event or information that could affect the stock price or shareholders' decisions. The specific details of the disclosure are not provided in the headline itself. Typically, such filings cover events like new contracts, changes in management, regulatory actions, financial results, or significant business developments.

Likely market impact

The actual impact on shareholders depends entirely on what specific event or information has been disclosed. Investors should read the full filing on the NSE/BSE website to understand the material details before making any investment decisions.